Homeopathy hearings

CFI’s De Dora to Testify at FDA Homeopathy Hearings April 20
As we mentioned in the previous issue of Cause & Effect, the FDA has announced that it will hold hearings on the marketing and regulation of homeopathic products, April 20 and 21, after years of urging by the Center for Inquiry. We have been invited to offer testimony at these hearings, and we now know that CFI’s director of public policy, Michael De Dora, will be among those leading off the first day of hearings with CFI’s testimony on Monday, April 20. In our statement to the press, Michael said, “If the marketers and manufacturers of homeopathic treatments want people to use their products as medicine, then they should have to meet the same standards of safety and effectiveness as any other medicine. Let’s see how they fare when they have the light of scientific rigor shined on them."
The hearings will be open to the public and livestreamed on the web. Michael is scheduled to begin at 9:50 am ET. To learn more about CFI’s advocacy of science-based medicine over pseudoscience, visit our Keep Healthcare Safe and Secular campaign website.

Well thats a positive step. Hoepfully it will lead somewhere. I hope they record the hearing. I wont be able to listen to it live.
In related Woo, Dr Oz was the subject of some more criticism today. unfortunately Coumbia Hospital is more interested in staying out of the fray than they are in standing up for science and good medicine.

I offered a comment on the homeopathy issue. There are over 900 comments, and so far the vast majority of them amount to “I tried it, I know it works, regulating it is an un-American plot by the evil pharmaceutical industry to keep us all sick.” I urge everyone to offer a comment because the tiny minority of believers in homeopathy are very outspoken and can easily stifle any real oversight if the rest of us don’t bother to participate.
Here’s the comment I sent if anyone wants to borrow any or all of it for their own statement:
The Food and Drug Administration (FDA) Proposed Rule: Homeopathic Product Regulation: Evaluating the Food and Drug Administration’s Regulatory Framework After a Quarter-Century; Public Hearing
ID: FDA-2015-N-0540-0001
I wish to offer my perspective on the regulation of homeopathic remedies by the FDA. As both a healthcare consumer and as a practicing veterinarian, I see the marketing and use of homeopathic products without legitimate scientific evidence of safety and efficacy as a danger to human and animal health. These products should be held to the same standards of evidence as any other drug if they are to be marketed with claims that they can treat or prevent disease in humans or animals.
The current regulatory structure effectively allows most homeopathic products to be marketed and used in humans and animals, with or without the guidance of a physician or veterinarian, without any of the scientific evidence of safety and efficacy required of most drugs regulated by the agency. This is a result of historical and political factors, but it leaves the public without the scientific information and guidance needed to make effective and informed decisions about the use of these products. The FDA itself acknowledges that ““FDA is not aware of scientific evidence to support homeopathy as effective.” (http://labels.fda.gov/)
Even National Center for Complementary and Alternative Medicine (NCCAM) of the
National Institutes of Health, which is specifically charged with investigating alternative
therapies, acknowledges the lack of scientific evidence for efficacy:
Most rigorous clinical trials and systematic analyses of the research on
homeopathy have concluded that there is little evidence to support homeopathy as
an effective treatment for any specific condition.
The scientific evidence is overwhelming and unequivocal that homeopathy provides no therapeutic benefit beyond the placebo effect of the consultation with a homeopath. Despite over 150 years of use and extensive research, no convincing evidence of a specific treatment effect has been produced. And there is also evidence that despite containing no active ingredients, homeopathic remedies can be harmful. When such products are mislabeled as homeopathic when they actual contain biologically active chemicals, or when they are used to treat serious illness in lieu of effective medical care, they can cause injury and death. Below I have provided a brief overview of this robust scientific evidence concerning homeopathy.
The evidence that homeopathic remedies are ineffective is an internationally accepted scientific consensus rejected only by dedicated practitioners of homeopathy and those they have misled. Given this consensus, it is an abrogation of the FDA’s responsibility to protect human and animal health to allow therapeutic and prevention claims to be made for these products. I recommend the agency take the following steps.

  1. Draft and submit to Congress a report identifying homeopathy as ineffective and recommending changes in the agency’s authorizing legislation to prohibit the marketing and use of homeopathy without fulfillment of the same new drug licensing requirements applied conventional drugs.
  2. Produce educational materials for healthcare providers and patients in both human and animal health fields identifying the ineffective nature of homeopathy for the treatment or prevention of human and animal disease.
  3. Require all OTC homeopathic products to carry a label similar to that required for dietary supplements under DSHEA, “This/these statement(s) have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease."
  4. Vigorously enforce regulations in both human and animal health fields prohibiting treatment and prevention claims for homeopathic remedies without fulfillment of the requirements of a NDA.

Good for you, McKenzie!